|
| |
|
The MedChem
Advantage |
|
|
MedChem
Partners is a unique medicinal chemistry provider.
We are entrepreneurs and scientists at heart and so we look
at medicinal chemistry a little
differently
than most companies. We
don’t have minimum requirements or lengthy procedures for project
initiation. Our goal is to
provide services as if we were your internal chemistry department.
We are comfortable with high risk projects and rapidly changing
priorities and provide rapid turnaround on most projects. We can
start and stop chemistry rapidly to match the work flow of your
company to help you conserve capital and resources.
Drug discovery
and development is a highly interdisciplinary undertaking which
draws on the expertise of many different areas.
MedChem Partners realizes this fact and
also knows that no one can be an expert in all these areas.
As a result we have formed collaborations with many other
experts in the drug discovery and development arena to enhance our
services. We have
relationships with experts in the area of computational
chemistry and crystallography, in vitro and e-ADME testing, in
vivo and PK screening, IP and project management, and preclinical
toxicology to name a few. Furthermore, if we do not possess the
expertise in house we can identify an external resource and help
manage them as an outsource partner.
At
MedChem Partners we strive to provide service which parallels
internal resources in terms of quality, speed and
responsiveness. We are committed to our clients and
their projects for both the short term as well as the long
term.
-
ü0-3 weeks lead time
-
üNo minimum FTE requirements
-
üVery flexible work plans
-
üNo advance notice needed to change or stop a
project
-
üClients always talk to bench scientist
-
üWilling to peruse a wide variety of projects
-
üAccess to Scifinder, ACD and journals on-line
|
|
|
-
-
ýMinimum FTE requirements
-
-
ýAdvance notice needed to change or stop a project
-
ýDifficult to talk to bench scientist
-
ýNormally not receptive to small or exploratory
projects
-
ýLimited on-line journal access, no Scifinder
|
|
|
|
